AHN

Mario Lemieux Foundation, Highmark Health Announce Major Gift to AHN Cardiovascular Institute, Establishing "The Mario Lemieux Center for Heart Rhythm Care"

Retrieved on: 
金曜日, 5月 10, 2024
Hockey, Patient, Data collection, Cardiovascular disease, Faculty, Chair, American Heart Association, Risk, Palpitations, Machine learning, Heart, Education, Cardiac electrophysiology, AHN, Stroke, Ventricular fibrillation, Death, Research, Atrial fibrillation, AGH, Fatigue, Artificial intelligence, EP, Joint, American College, Joint Commission, Disability, Cardiology, Pharmaceutical industry

PITTSBURGH, May 10, 2024 /PRNewswire/ -- Representatives from the Mario Lemieux Foundation and Highmark Health today announced a major collaborative gift to Allegheny Health Network's (AHN) Cardiovascular Institute that will further strengthen the organization's nationally recognized cardiac electrophysiology (EP) program. The joint commitment, totaling $5 million, will formally establish "The Mario Lemieux Center for Heart Rhythm Care" at AHN.

Key Points: 
  • The joint commitment, totaling $5 million, will formally establish "The Mario Lemieux Center for Heart Rhythm Care" at AHN.
  • Lemieux Foundation, Highmark Health Announce Major Gift to AHN, Establish The Mario Lemieux Center for Heart Rhythm Care
    This is the second philanthropic gift to AHN's EP program from the Mario Lemieux Foundation.
  • In 2019, the Foundation created the "Mario Lemieux Innovation and Research Fund" through a $1 million gift, which also was matched by Highmark Health.
  • In 2005, hockey legend Mario Lemieux was diagnosed with atrial fibrillation (AFib), the most prevalent heart rhythm disorder in the country.

AHN, Innovation Works AlphaLab Health Joint Venture Receives $10 Million Grant to Create Revolving Investment Fund

Retrieved on: 
火曜日, 5月 7, 2024
Investment, CRS, Community health, IW, Infection, Cytokine release syndrome, Machine learning, Immunotherapy, Innovation, MD, Partnership, AHN, Allegheny Health Network, Obstructive sleep apnea, Immune system, OSA

BELLEVUE, Pa., May 7, 2024 /PRNewswire-PRWeb/ -- AlphaLab Health, an accelerator program developed by Innovation Works and Allegheny Health Network for life-sciences startups in the Pittsburgh region, has received a $10 million grant from an anonymous donor to create an evergreen fund.

Key Points: 
  • The grant establishes the AlphaLab Health Revolving Investment Fund, which will support startups in the accelerator program.
  • The investment returns generated by the fund will create a permanent, self-sustaining source of revenue that will be reinvested into future AlphaLab startups.
  • AlphaLab Health is based at Allegheny Health Network (AHN) Suburban, the former Bellevue acute-care hospital that has been reinvented as a community innovation hub.
  • "This significant grant will propel AlphaLab Health into the next decade of health care innovation and beyond," said Mitch Beckman, Chief Development Officer at Highmark Health, parent company of AHN.

Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032

Retrieved on: 
金曜日, 5月 3, 2024
PFS, United Nations, FDA, Mutation, Daiichi Sankyo, Pancreatic cancer, Bio-Rad Laboratories, MBC, ONC, Prostate cancer, Paper, Behavior, Breast cancer, AstraZeneca, Paclitaxel, Fast track (FDA), Woman, TSX, CELC, DdPCR, Oncolytics Biotech, Ageing, Therapy, Pelareorep, Combination therapy, Combination, Mutant, Survival, Research, Cancer, MRD, Progression-free survival, Marketing, Immunotherapy, AHN, PCR, United, Patient, Type, Pharmaceutical industry

VANCOUVER, BC, May 3, 2024 /PRNewswire/ -- According to a "highly troubling" new study, the rising number of cancer cases in young people is being attributed to "accelerated aging." Further alarm is being spread by the United Nations, whose health authorities are predicting global cancer cases to rise around 77% by 2050, with richer countries expected to have the greatest absolute increase in cancer, with an additional 4.8 million new cases predicted in 2050. With the global cancer immunotherapy market projected by analysts at Custom Market Insights to reach US$314.4 billion by 2032, growing at a 7.2% CAGR, the biotech sector continues to make significant developments in cancer treatment and diagnostics, with recent updates coming from Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), Celcuity Inc. (NASDAQ: CELC), Olema Pharmaceuticals, Inc. (NASDAQ: OLMA), Bio-Rad Laboratories, Inc. (NYSE: BIO), and AstraZeneca PLC (NASDAQ: AZN).

Key Points: 
  • "A key focus for Oncolytics in 2024 is defining the regulatory path for pelareorep in breast cancer treatment," said Matt Coffey, President and CEO of Oncolytics.
  • "We are optimistic that pelareorep, in combination with paclitaxel, could significantly enhance clinical outcomes for patients with HR+/HER2- metastatic breast cancer.
  • Oncolytics Biotech requested to meet with the FDA in Q2 2024 to finalize the registrational trial design and objectives for using pelareorep to treat metastatic breast cancer.
  • "These data underscore the potential for treatment with ENHERTU across the spectrum of HR-positive breast cancer, further redefining the treatment of metastatic breast cancer."

Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032

Retrieved on: 
金曜日, 5月 3, 2024
PFS, United Nations, FDA, Mutation, Daiichi Sankyo, Pancreatic cancer, Bio-Rad Laboratories, MBC, ONC, Prostate cancer, Paper, Behavior, Breast cancer, AstraZeneca, Paclitaxel, Fast track (FDA), Woman, TSX, CELC, DdPCR, Oncolytics Biotech, Ageing, Therapy, Pelareorep, Combination therapy, Combination, Mutant, Survival, Research, Cancer, MRD, Progression-free survival, Marketing, Immunotherapy, AHN, PCR, United, Patient, Type, Pharmaceutical industry

VANCOUVER, BC, May 3, 2024 /PRNewswire/ -- According to a "highly troubling" new study, the rising number of cancer cases in young people is being attributed to "accelerated aging." Further alarm is being spread by the United Nations, whose health authorities are predicting global cancer cases to rise around 77% by 2050, with richer countries expected to have the greatest absolute increase in cancer, with an additional 4.8 million new cases predicted in 2050. With the global cancer immunotherapy market projected by analysts at Custom Market Insights to reach US$314.4 billion by 2032, growing at a 7.2% CAGR, the biotech sector continues to make significant developments in cancer treatment and diagnostics, with recent updates coming from Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), Celcuity Inc. (NASDAQ: CELC), Olema Pharmaceuticals, Inc. (NASDAQ: OLMA), Bio-Rad Laboratories, Inc. (NYSE: BIO), and AstraZeneca PLC (NASDAQ: AZN).

Key Points: 
  • "A key focus for Oncolytics in 2024 is defining the regulatory path for pelareorep in breast cancer treatment," said Matt Coffey, President and CEO of Oncolytics.
  • "We are optimistic that pelareorep, in combination with paclitaxel, could significantly enhance clinical outcomes for patients with HR+/HER2- metastatic breast cancer.
  • Oncolytics Biotech requested to meet with the FDA in Q2 2024 to finalize the registrational trial design and objectives for using pelareorep to treat metastatic breast cancer.
  • "These data underscore the potential for treatment with ENHERTU across the spectrum of HR-positive breast cancer, further redefining the treatment of metastatic breast cancer."

AHN Brings Outpatient Services to new Uniontown Facility

Retrieved on: 
金曜日, 4月 12, 2024
Physician, Cancer, Mammography, L&D, Woman, Suite, Cardiology, AHN, Allegheny Health Network, Federation, Obesity, Medical imaging, Smoking, Patient, PPCP, Neurology, Neurosurgery, Sports medicine, OB, Easy street, Nursing

UNIONTOWN, Pa., April 12, 2024 /PRNewswire-PRWeb/ -- Allegheny Health Network (AHN) today announced that it is now offering a range of clinical, specialty services at a new location in Uniontown. The recently opened 27,500-square-foot multi-specialty outpatient center will enable care coordination at the site between Preferred Primary Care Physicians (PPCP) and AHN.

Key Points: 
  • UNIONTOWN, Pa., April 12, 2024 /PRNewswire-PRWeb/ -- Allegheny Health Network (AHN) today announced that it is now offering a range of clinical, specialty services at a new location in Uniontown.
  • The recently opened 27,500-square-foot multi-specialty outpatient center will enable care coordination at the site between Preferred Primary Care Physicians (PPCP) and AHN.
  • AHN will also feature a full spectrum of women's health offerings at the new facility, including obstetric (OB) services, preventative gynecologic care, and the AHN Perinatal Hope program for women with substance use disorders.
  • The opening of the new Uniontown facility is just one component of AHN's strategy for serving the southwestern corridor of Pennsylvania.

Mutual Aid EMS Clinicians Recognized at Allegheny Health Network Trauma Symposium

Retrieved on: 
月曜日, 4月 8, 2024
General Health, Other Health, Health, Law Enforcement, Emergency Services, Public Policy, Government, Tranexamic acid, Face, Physician, Patient, Allegheny Health Network, AHN, Trauma, PAS, Emergency medical technician, EMS, Nursing, EMT

Three personnel from Mutual Aid Ambulance Service, Inc., the largest ambulance service in Westmoreland County, Pennsylvania, were recognized at the 10th Annual Allegheny Health Network (AHN) Trauma Symposium.

Key Points: 
  • Three personnel from Mutual Aid Ambulance Service, Inc., the largest ambulance service in Westmoreland County, Pennsylvania, were recognized at the 10th Annual Allegheny Health Network (AHN) Trauma Symposium.
  • On March 6th, 2024 District Chief Benjamin Tingle, Paramedic Nathaniel Zanoni, and EMT Richard DeForrest were presented with challenge coins for their actions caring for a critically injured patient.
  • The three were honored for their efforts on a recent emergency call involving a gunshot victim.
  • Mutual Aid Ambulance Service employs over 280 licensed and certified personnel who receive advanced training and are required to maintain good standing with the National Registry of Emergency Medical Technicians.

ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

Retrieved on: 
木曜日, 3月 21, 2024
Research, Health, Commercialization, Transplant, CKD, Risk, Patient, AHN, Kidney failure, Biostatistics, CBO, Business development, Overalls, Quality of life, Trial of the century, Kidney disease, CVS Health, Clinical trial, EGFR, Chronic kidney disease, Dialysis, Baxter International, Type, Pharmaceutical industry

WINSTON-SALEM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced financial results for the year ended December 31, 2023.

Key Points: 
  • WINSTON-SALEM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced financial results for the year ended December 31, 2023.
  • In November, the Company announced Dr. Bruce Culleton assumed the role of the CEO and joined the ProKidney board of directors.
  • Dr. Culleton joined ProKidney in July 2023 as Executive Vice President of Clinical Development and Commercialization.
  • Mr. Periera-Kamath had previously joined ProKidney in July 2023 as Vice President of Business Development & Innovative Solutions.

Highmark Health, AHN Announce Plans to Transform Allegheny General Hospital Campus

Retrieved on: 
木曜日, 4月 4, 2024
Magnet, Temperature, Conference, Health, Growth, Bed, Transplant, Caregiver, Patient, Allegheny Health Network, Allegheny General Hospital, AHN, City, Research, Trauma, IMP, Electrophysiology, MD, Operating, AGH, Investment, System, Hospital, Heart, CVI, Safety, Lighting, Nuclear medicine, DSM-IV codes, Nursing

PITTSBURGH, April 4, 2024 /PRNewswire-PRWeb/ -- Highmark Health and Allegheny Health Network (AHN) officials today reinforced a commitment to their Living Health model by announcing plans for continued significant investments in the network. Specifically, Allegheny General Hospital (AGH), AHN's flagship academic medical center, will be transformed with a new cardiovascular tower and emergency department, among other upgrades, further advancing and modernizing the hospital's care delivery and technological capabilities.

Key Points: 
  • PITTSBURGH, April 4, 2024 /PRNewswire-PRWeb/ -- Highmark Health and Allegheny Health Network (AHN) officials today reinforced a commitment to their Living Health model by announcing plans for continued significant investments in the network.
  • "Creating high-quality patient experiences and outcomes, and equitable access, through personalized care models designed to promote wellness and address health needs, is our goal at AHN.
  • The centerpiece of the AGH campus transformation is construction of a new patient tower which will house the nationally recognized services of the AHN Cardiovascular Institute (CVI).
  • One such project already underway at the hospital is the creation of a new hub for the AHN Neuroscience Institute.

Highmark Health announces Craig Riner appointment to Executive Vice President, Chief Marketing Officer

Retrieved on: 
火曜日, 3月 26, 2024
Marketing strategy, Rite Aid, Highmark, Health, Allegheny Health Network, AHN, Senior, Marketing, Advertising, Management

PITTSBURGH, March 26, 2024 /PRNewswire/ -- Highmark Health today announced that Craig Riner has been appointed Executive Vice President and Chief Marketing Officer.

Key Points: 
  • PITTSBURGH, March 26, 2024 /PRNewswire/ -- Highmark Health today announced that Craig Riner has been appointed Executive Vice President and Chief Marketing Officer.
  • In this role, he will oversee marketing, brand experience, advertising and customer engagement across the entire organization, including the Highmark Health Plan, Allegheny Health Network (AHN) and its diversified businesses.
  • Previously, he served as Senior Vice President of Strategic Marketing for Highmark Health, where he oversaw all customer insights, marketing planning, campaign development, media, sponsorships, and marketing analytics across the enterprise.
  • Prior to Highmark Health, Riner was Vice President of Marketing at Rite Aid Corporation, where he led the development and launch of Rite Aid's customer loyalty program.

Allegheny Health Network to Raise Minimum Starting Wage to $18 per Hour

Retrieved on: 
金曜日, 3月 15, 2024
Retirement, Allegheny Health Network, AHN, Parental leave

PITTSBURGH, March 15, 2024 /PRNewswire-PRWeb/ -- Allegheny Health Network (AHN) today announced plans to boost the organization's minimum hourly wage to $18 at the end of March, more than doubling the state's current minimum of $7.25 per hour.

Key Points: 
  • Pittsburgh-based Allegheny Health Network, a 14-hospital health system, today announced plans to boost the organization's minimum hourly wage to $18 at the end of March, more than doubling the state's current minimum of $7.25 per hour.
  • PITTSBURGH, March 15, 2024 /PRNewswire-PRWeb/ -- Allegheny Health Network (AHN) today announced plans to boost the organization's minimum hourly wage to $18 at the end of March, more than doubling the state's current minimum of $7.25 per hour.
  • The increase will affect AHN employees who are at or near the network's current minimum hourly wage of $16 an hour, representing an increase of nearly 9 percent for approximately 1,700 team members.
  • AHN's parent company, Highmark Health, also announced today the implementation of an $18 per hour minimum wage elsewhere within the organization, which will take effect by the end of the year.